Publications

Publications

Filter Results: (341) Arrow Down

Show Results For

← Page 6 of 341 Results →
  • December 2002
  • Article

Knowledge Seeking and Location Choice of Foreign Direct Investment in the United States

By: Juan Alcacer and Wilbur Chung
To what extent do firms go abroad to access technology available in other locations? This paper examines whether and when state technical capabilities attract foreign investment in manufacturing from 1987-1993. We find that on average state R&D intensity does not... View Details
Keywords: Knowledge Acquisition; Foreign Direct Investment; Research and Development; Information Technology; Production; Geographic Location; United States
Related

    Gerald Zaltman

    *Joined Harvard Faculty: 1991
    Prior Faculty Appointments: Northwestern University, 1968-75;
    University of Pittsburgh, 1975-91

    *Doctoral Degree in Sociology Received from: The John Hopkins University;
    MBA Degree Received from: The University of... View Details

    Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
    • January 2018 (Revised January 2019)
    • Case

    ZappRx

    By: Jeffrey J. Bussgang and Olivia Hull
    In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare diseases, has attracted interest... View Details
    Keywords: Speciality Drugs; Hub Services; Pivot; Speciality Prescriptions; Health Care and Treatment; Customization and Personalization; Internet and the Web; Business Model; Decision Choices and Conditions; Pharmaceutical Industry; Massachusetts
    Related
    • 30 Oct 2007
    • First Look

    First Look: October 30, 2007

    this instructor's guide an invaluable resource. Purchase the instructor's guide: http://www.hepg.org/hep/Book/75 America the Principled: 6 Opportunities for Becoming a Can-Do Nation Once Again Author:Rosabeth Moss Kanter Publication:New... View Details
    Keywords: Sean Silverthorne
    • Web

    Hiring Organizations

    AxmedRx Ayala Corporation Ayala Land, Inc. Azolla Ventures B B Capital Bain & Company Bain Capital Bain Capital Ventures Balance Rock Partners Bank of America Barry-Wehmiller BC Partners BCG Digital Ventures Beanstalk Benefits Beartown... View Details
    • November 2017
    • Case

    The 'Wonder Drug' That Killed Babies

    By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
    In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
    Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Pharmaceutical Industry; United States; United Kingdom; Australia; Germany; Europe
    Related

      Regina E. Herzlinger

      Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and serve on many established and start-up corporate health care/medical... View Details

      Keywords: health care; insurance industry; medical devices; retailing; digital health
      • 11 Sep 2012
      • Working Paper Summaries

      Spatial Organization of Firms: Internal and External Agglomeration Economies and Location Choices Through the Value Chain

      Keywords: by Juan Alcácer & Mercedes Delgado

        Max H. Bazerman

        Max H. Bazerman is Jesse Isidor Straus Professor of Business Administration at the Harvard Business School. His recent books... View Details
        Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals
        • Web

        Employment Data Trends

        Employment Data Trends Employment Data Trends Trends Career Data Internship Data Trends by Industry 2020 2021 2022 2023 2024 Consulting 24% 23% 26% 25% 18% Consumer Products 3% 3% 3% 4% 3% Entertainment / Media 2% 3% 3% 1% 3% Health Care 7% 6% 5% 5% 6% Biomed / View Details

          Srikant M. Datar

          Srikant M. Datar became the eleventh dean of Harvard Business School on 1 January 2021. During his tenure as a faculty member, he served as Senior Associate Dean for University Affairs (including Faculty Chair of the Harvard Innovation Lab), for Research, for... View Details

          Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

            Paul A. Gompers

            Paul Gompers, Professor of Business Administration at the Harvard Business School, specializes in research on financial issues related to start-up, high growth, and newly public companies. Professor Gompers has an appointment in both the View Details
            Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

              Joshua D. Margolis

              Joshua Margolis is James Dinan and Elizabeth Miller Professor of Business Administration and the Unit Head for the Organizational Behavior unit. He is also Faculty Chair of the Program for Leadership Development. His research and teaching revolve around leadership... View Details

              Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
              • 13 Jul 2020
              • Research & Ideas

              Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

              As chairman and CEO of the leading vaccine producer in the world, pharmaceutical giant Merck & Co., Ken Frazier has one of the highest-profile positions in global business. But Frazier, who is leading one of the firms on a charge to... View Details
              Keywords: by Staff; Pharmaceutical

                Malcolm P. Baker

                Malcolm Baker is the Robert G. Kirby Professor of Business Administration at the Harvard Business School, where he teaches the required course in finance and a short immersive program on investing in life sciences.

                His research is in the... View Details

                Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

                  Krishna G. Palepu

                  KRISHNA G. PALEPU is the Ross Graham Walker Professor of Business Administration, and has served previously as Senior Advisor to the President of Harvard University, and Senior Associate Dean... View Details

                  Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
                  • 11 Apr 2024
                  • In Practice

                  Why Progress on Immigration Might Soften Labor Pains

                  innovation outcomes, and in many ways. Here are three: Knowledge is shared and then recombined. Knowledge is transferred from the home countries of the migrants to the US, we found in a study we did with data from US pharmaceutical... View Details
                  Keywords: by Rachel Layne

                    Rohit Deshpande

                    Rohit Deshpandé is a Baker Foundation Professor and Sebastian S. Kresge Professor of Marketing, Emeritus at Harvard Business School, where he has been teaching in the Advanced Management Program,... View Details

                    Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals

                      Nitin Nohria

                      Nitin Nohria served as the tenth dean of Harvard Business School from 2010-2020. He previously served as co-chair of the Leadership Initiative, Senior Associate Dean of Faculty Development, and Head of the Organizational Behavior unit.

                      As Dean, building on... View Details

                      Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
                      • 21 Feb 2018
                      • Research & Ideas

                      When a Competitor Abandons the Market, Should You Advance or Retreat?

                      Terminations: Learning from Competitors’ R&D Failures, Krieger explores how pharmaceutical companies choose to react strategically when a competitor exits the market during the development stage. These companies may decide further... View Details
                      Keywords: by Rachel Layne; Pharmaceutical; Pharmaceutical